On September 24, 2015, The Second Meeting of 10th PhIRDA General Assembly elected new leadership of the association:

Annual Chairman:

2015-2016 Annual Chairman:

Jiang Hualiang, Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

2016-2017 Annual Chairman Candidate:

Ding Lieming, Chairman of the Board, Beta Pharmaceutical Co., Ltd.

Vice-Presidents:

Jiang Hualiang, Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Ding Lieming, Chairman of the Board, Beta Pharmaceutical Co., Ltd.

Song Ruilin, Executive President of PhIRDA

Sun Piaoyang, Chairman of the Board, Jiangsu Hengrui Medicine Co., Ltd.

Yan Xijun, Chairman of the Board, Tasly Holding Group

Chen Qiyu, Chairman of the Board, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Zhang Boli, President, Tianjin University of Traditional Chinese Medicine; Academician, Chinese Academy Engineering

Cai Dongchen, Chairman of the Board, China Shijiazhuang Pharmaceutical Group Co., Ltd.

Lou Dingbo, Chairman of the Board, Shanghai Pharmaceuticals Holding Co., Ltd.

Ren Jinsheng, Chairman of the Board, Simcere Pharmaceutical Group

Shi Shengyi, Secretary of the Board, Sinopharma Group Corporation; Chairman of the Board, Chinese Journal of New Drugs

Jiang Jiandong, Director, Institute of Materia Medica, Chinese Academy of Medical Sciences

Ke Zunhong, Chairman of the Board, Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Secretary-General:

Feng Lan